Investing
It was a slow start to the week for gold, but it didn’t take long for the price to pick up. The yellow metal...
Connect with us
Hi, what are you looking for?
Daily Market Solution
- Stock
Why Trump’s iPhone tariff threat might not be enough to bring production to the U.S.
Trump clears Nippon merger with U.S. Steel
United Airlines reaches ‘industry-leading’ labor deal with flight attendants, union says
FTC drops Biden-era suit accusing Pepsi of price discrimination
How UnitedHealthcare became the face of America’s health insurance frustrations
- Economy
- Editor’s Pick
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
American creating deepfakes targeting Harris works with Russian intel, documents show
Early voting in Wisconsin slowed by label printing problems
- Latest News
Trump talks with Putin, spars with South African leader, threatens EU tariff hike in 18th week in office
WATCH: GOP senators rail against staggering $4.7 trillion in untraceable Treasury payments
SCOOP: House Republicans request ban on federally funded ‘transgender animal’ experiments in 2026 budget
DAVID MARCUS: Tax-free overtime could be midterm magic for GOP
Trump unleashes US nuclear renaissance with bold executive orders
Investing
It was a slow start to the week for gold, but it didn’t take long for the price to pick up. The yellow metal...
Investing
It was a slow start to the week for gold, but it didn’t take long for the price to pick up. The yellow metal...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer of a world-class platform...
Investing
Astute Metals NL (ASX: ASE) (“ASE�, “Astute� or “the Company�) is pleased to report assay results from the first of six holes completed as...
Investing
Astute Metals NL (ASX: ASE) (“ASE�, “Astute� or “the Company�) is pleased to report assay results from the first of six holes completed as...